Volume 79, Issue 9 pp. 2547-2550
LETTER

Plasma proteomics analysis of patients with chronic spontaneous urticaria reveals significant associations with key disease characteristics but not with response to omalizumab treatment

Misbah Noshela Ghazanfar

Corresponding Author

Misbah Noshela Ghazanfar

Department of Dermato-Venereology & Wound Healing Centre, Urticaria Center of Reference and Excellence (UCARE), Bispebjerg Hospital, Copenhagen, Denmark

Correspondence

Misbah Noshela Ghazanfar, Department of Dermato-Venereology & Wound Healing Centre, Bispebjerg Hospital, Bispebjerg Bakke 23, DK-2400 Copenhagen NV, Denmark.

Email: [email protected]

Search for more papers by this author
Valdemaras Petrosius

Valdemaras Petrosius

Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark

Search for more papers by this author
Jennifer Astrup Sørensen

Jennifer Astrup Sørensen

Department of Dermato-Venereology & Wound Healing Centre, Urticaria Center of Reference and Excellence (UCARE), Bispebjerg Hospital, Copenhagen, Denmark

Search for more papers by this author
Ditte Georgina Zhang

Ditte Georgina Zhang

Department of Dermato-Venereology & Wound Healing Centre, Urticaria Center of Reference and Excellence (UCARE), Bispebjerg Hospital, Copenhagen, Denmark

Search for more papers by this author
Zarqa Ali

Zarqa Ali

Department of Dermato-Venereology & Wound Healing Centre, Urticaria Center of Reference and Excellence (UCARE), Bispebjerg Hospital, Copenhagen, Denmark

Search for more papers by this author
Marcus Maurer

Marcus Maurer

Urticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany

Search for more papers by this author
Emek Kocatürk

Emek Kocatürk

Urticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany

Department of Dermatology, Koç University School of Medicine, Istanbul, Turkey

Search for more papers by this author
Valdemar Wendelboe Nielsen

Valdemar Wendelboe Nielsen

Department of Dermato-Venereology & Wound Healing Centre, Urticaria Center of Reference and Excellence (UCARE), Bispebjerg Hospital, Copenhagen, Denmark

Search for more papers by this author
Simonas Savickas

Simonas Savickas

Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark

Search for more papers by this author
Ulrich auf dem Keller

Ulrich auf dem Keller

Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark

Search for more papers by this author
Erwin M. Schoof

Erwin M. Schoof

Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark

Search for more papers by this author
Simon Francis Thomsen

Simon Francis Thomsen

Department of Dermato-Venereology & Wound Healing Centre, Urticaria Center of Reference and Excellence (UCARE), Bispebjerg Hospital, Copenhagen, Denmark

Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for more papers by this author
First published: 26 May 2024
Citations: 1
First page image

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.